ID: ALA4781269
Chembl Id: CHEMBL4781269
PubChem CID: 162662802
Max Phase: Preclinical
Molecular Formula: C13H15ClN2O2S
Molecular Weight: 298.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(Cl)cc(NC(=O)[C@@H]2CSCCC(=O)N2)c1
Standard InChI: InChI=1S/C13H15ClN2O2S/c1-8-4-9(14)6-10(5-8)15-13(18)11-7-19-3-2-12(17)16-11/h4-6,11H,2-3,7H2,1H3,(H,15,18)(H,16,17)/t11-/m0/s1
Standard InChI Key: SRBFFACUVCRNTP-NSHDSACASA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 298.80 | Molecular Weight (Monoisotopic): 298.0543 | AlogP: 2.21 | #Rotatable Bonds: 2 |
| Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 10.85 | CX Basic pKa: ┄ | CX LogP: 2.06 | CX LogD: 2.06 |
| Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.88 | Np Likeness Score: -1.48 |
| 1. Kent CN,Fulton MG,Stillwell KJ,Dickerson JW,Loch MT,Rodriguez AL,Blobaum AL,Boutaud O,Rook JL,Niswender CM,Conn PJ,Lindsley CW. (2021) Discovery and optimization of a novel CNS penetrant series of mGlu PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model., 37 [PMID:33556572] [10.1016/j.bmcl.2021.127838] |
Source(1):
